Pricing Log in Create free account

Aspira Women's Health Inc. (AWHL) vs XWELL, Inc. (XWEL)

Aspira Women's Health Inc. and XWELL, Inc. are both Diagnostics & Research companies. XWELL, Inc. is the larger, with a market value of $7.5M against $2.4M — 3.1× the size. XWELL, Inc. grew revenue faster over the last twelve months: −7.58% against −8.00%. Aspira Women's Health Inc. has the higher net margin (−117.1% vs −117.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, XWELL, Inc. leads on 9 and Aspira Women's Health Inc. on 7.

Valuation

Metric AWHL XWEL Diagnostics & Research median
P/E n/m n/m 35.56
P/S 1.19 0.22 4.37
P/B n/m 0.75 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m 0.02 24.35
EV/Sales 1.36 (0.01) 5.51
Earnings yield (106.09%) (728.77%) (1.89%)
Free cash flow yield (46.46%) (217.51%) (0.15%)

Profitability

Metric AWHL XWEL Diagnostics & Research median
Gross margin 58.78% 34.34% 50.89%
Operating margin (80.75%) (61.31%) (8.57%)
Net margin (117.07%) (117.83%) (6.37%)
Free cash flow margin (55.32%) (47.65%) 0.00%
Return on equity 201.29% (557.21%) (2.92%)
Return on assets (213.58%) (155.10%) (6.71%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AWHL XWEL Diagnostics & Research median
Revenue growth (TTM) (8.00%) (7.58%) 7.69%
EPS growth (last fiscal year) 60.22% (38.80%) 25.92%
Revenue growth, 5-year CAGR 14.66% 28.35% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AWHL XWEL Diagnostics & Research median
Debt to equity (0.27) 0.00 0.11
Current ratio 0.52 2.27 2.02
Net debt to EBITDA 0.00 (0.08) 0.70

Dividend

Metric AWHL XWEL Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric AWHL XWEL Diagnostics & Research median
Market cap 2.44m 7.45m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack